Virogenomics: A novel approach to antiviral drug discovery

Drug Discovery Today

Volumn 6, Issue 12, 2001, Pages 621-627

  Früh, Klaus ^a   Simmen, Kenneth ^b   Luukkonen, B G Mattias ^b   Bell, Yolanda C ^b   Ghazal, Peter ^c  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b R W JOHNSON PHARMACEUTICAL RES I   (United States)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CELL PROTEIN; INTERFERON; MESSENGER RNA; PROSTAGLANDIN;

DNA MICROARRAY; DRUG RESEARCH; DRUG TARGETING; GENE EXPRESSION; GENE SEQUENCE; HOST CELL; HOST PARASITE INTERACTION; HUMAN; MEDICAL GENETICS; NONHUMAN; OPEN READING FRAME; REVIEW; VIROLOGY; VIRUS CELL INTERACTION; VIRUS GENOME; VIRUS INFECTION; VIRUS REPLICATION;

EID: 0035368747     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(01)01808-6     Document Type: Review

References (56)

1. Initial sequencing and analysis of the human genome
2. The sequence of the human genome
3. The impact of genomics on drug discovery
4. Strategies for antiviral drug discovery
5. The emerging role of fusion inhibitors in HIV infection
6. Chemokine receptors - future therapeutic targets for HIV?
7. Backbone cyclic peptide, which mimics the nuclear localization signal of human immunodeficiency virus type 1 matrix protein, inhibits nuclear import and virus production in nondividing cells
8. Inhibitory effect of 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)1H-imidazole on HCMV DNA replication and permissive infection
9. Inhibition of NF-κB induces apoptosis of KSHV-infected primary effusion lymphoma cells
10. Activation of heat-shock response by an adenovirus is essential for virus replication
11. Inhibition of cellular Cdk2 activity blocks human cytomegalovirus replication
12. Requirement for cellular cyclin-dependent kinases in herpes simplex virus replication and transcription
13. A PPxY motif within the VP40 protein of Ebola virus interacts physically and functionally with a ubiquitin ligase: implications for filovirus budding
14. Ubiquitin is part of the retrovirus budding machinery
15. Proteasome inhibition interferes with gag polyprotein processing, release, and maturation of HIV-1 and HIV-2
16. A role for ubiquitin ligase recruitment in retrovirus release
17. A protein-based therapeutic for human cytomegalovirus infection
18. Biomedical discovery with DNA arrays
19. Exploring the metabolic and genetic control of gene expression on a genomic scale
20. Accessing genetic information with high-density DNA arrays
21. Microarrays under the microscope
22. Microarray techniques in pathology: tool or toy?
23. The transcriptional program in the response of human fibroblasts to serum
24. Diverse signaling pathways activated by growth factor receptors induce broadly overlapping, rather than independent, sets of genes
25. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring
26. How the host 'sees' pathogens: global gene expression responses to infection
27. Cellular gene expression altered by human cytomegalovirus: global monitoring with oligonucleotide arrays
28. Use of differential display analysis to assess the effect of human cytomegalovirus infection on the accumulation of cellular RNAs: induction of interferon-responsive RNAs
29. Cloning differentially expressed mRNAs
30. Identification of genes differentially regulated by interferon α, β, or γ using oligonucleotide arrays
31. Human cytomegalovirus inhibits IFN-α-stimulated antiviral and immunoregulatory responses by blocking multiple levels of IFN-α signal transduction
32. Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the Jak/Stat pathway
33. Herpes simplex virus triggers and then disarms a host antiviral response
34. Efficient activation of viral genomes by levels of herpes simplex virus ICP0 insufficient to affect cellular gene expression or cell survival
35. Identification of eukaryotic mRNAs that are translated at reduced cap binding complex eIF4F concentrations using a cDNA microarray
36. Induction of host gene expression following infection of chicken embryo fibroblasts with oncogenic Marek's disease virus
37. Modulation of cellular and viral gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus
38. KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway
39. Microarray analysis identifies interferon-inducible genes and Stat-1 as major transcriptional targets of human papillomavirus type 31
40. Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-κB-responsive genes in cervical keratinocytes
41. Global impact of influenza virus on cellular pathways is mediated by both replication-dependent and -independent events
42. Large-scale monitoring of host cell gene expression during HIV-1 infection using cDNA microarrays
43. A human hepatoma cell line expressing hepatitis C virus nonstructural proteins tightly regulated by tetracycline
44. Host gene regulation during coxsackievirus B3 infection in mice: assessment by microarrays
45. Gene expression analysis via cDNA microrays of laser capture microdissected cells from fixed tissue
46. DNA microarrays of the complex human cytomegalovirus genome: profiling kinetic class with drug sensitivity of viral gene expression
47. A subset of viral transcripts packaged within human cytomegalovirus particles
48. Global analysis of HSV type 1 transcription using an oligonucleotide-based DNA microarray
49. Kaposi's sarcoma-associated herpesvirus latent and lytic gene expression as revealed by DNA arrays
50. HHV8 infection and growth regulation of dermal microvascular endothelial cells
51. Inhibition of c-kit receptor tyrosine kinase activity by STI 571, a selective tyrosine kinase inhibitor
52. Lessons learned from the development of an Abl tyrosine kinase inhibitor for chronic myelogenous leukemia